Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Connection

Susan Lana to Dog Diseases

This is a "connection" page, showing publications Susan Lana has written about Dog Diseases.

 
Connection Strength
 
 
 
6.523
 
  1. Wolf-Ringwall A, Lopez L, Elmslie R, Fowler B, Lori J, Sfiligoi G, Skope A, Arnold E, Hughes KL, Thamm DH, Ehrhart EJ, Avery AC, Lana SE. Prospective evaluation of flow cytometric characteristics, histopathologic diagnosis and clinical outcome in dogs with naïve B-cell lymphoma treated with a 19-week CHOP protocol. Vet Comp Oncol. 2020 Sep; 18(3):342-352.
    View in: PubMed
    Score: 0.534
  2. Selmic LE, Lafferty MH, Kamstock DA, Garner A, Ehrhart NP, Worley DR, Withrow SJ, Lana SE. Outcome and prognostic factors for osteosarcoma of the maxilla, mandible, or calvarium in dogs: 183 cases (1986-2012). J Am Vet Med Assoc. 2014 Oct 15; 245(8):930-8.
    View in: PubMed
    Score: 0.375
  3. Selmic LE, Burton JH, Thamm DH, Withrow SJ, Lana SE. Comparison of carboplatin and doxorubicin-based chemotherapy protocols in 470 dogs after amputation for treatment of appendicular osteosarcoma. J Vet Intern Med. 2014 Mar-Apr; 28(2):554-63.
    View in: PubMed
    Score: 0.358
  4. Warry E, Bohn A, Emanuelli M, Thamm D, Lana S. Disease distribution in canine patients with acanthocytosis: 123 cases. Vet Clin Pathol. 2013 Dec; 42(4):465-70.
    View in: PubMed
    Score: 0.353
  5. Marcus EC, Marolf A, Thamm DH, Lana SE. What is your diagnosis? Extraskeletal osteosarcoma. J Am Vet Med Assoc. 2012 Feb 01; 240(3):265-6.
    View in: PubMed
    Score: 0.311
  6. Warry E, Hansen RJ, Gustafson DL, Lana SE. Pharmacokinetics of cyclophosphamide after oral and intravenous administration to dogs with lymphoma. J Vet Intern Med. 2011 Jul-Aug; 25(4):903-8.
    View in: PubMed
    Score: 0.296
  7. Lana S, U'ren L, Plaza S, Elmslie R, Gustafson D, Morley P, Dow S. Continuous low-dose oral chemotherapy for adjuvant therapy of splenic hemangiosarcoma in dogs. J Vet Intern Med. 2007 Jul-Aug; 21(4):764-9.
    View in: PubMed
    Score: 0.226
  8. Kraft S, Randall E, Wilhelm M, Lana S. Development of a whole body magnetic resonance imaging protocol in normal dogs and canine cancer patients. Vet Radiol Ultrasound. 2007 May-Jun; 48(3):212-20.
    View in: PubMed
    Score: 0.224
  9. Gaines PJ, Powell TD, Walmsley SJ, Estredge KL, Wisnewski N, Stinchcomb DT, Withrow SJ, Lana SE. Identification of serum biomarkers for canine B-cell lymphoma by use of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry. Am J Vet Res. 2007 Apr; 68(4):405-10.
    View in: PubMed
    Score: 0.222
  10. Lana SE, Kogan LR, Crump KA, Graham JT, Robinson NG. The use of complementary and alternative therapies in dogs and cats with cancer. J Am Anim Hosp Assoc. 2006 Sep-Oct; 42(5):361-5.
    View in: PubMed
    Score: 0.214
  11. Lana S, Plaza S, Hampe K, Burnett R, Avery AC. Diagnosis of mediastinal masses in dogs by flow cytometry. J Vet Intern Med. 2006 Sep-Oct; 20(5):1161-5.
    View in: PubMed
    Score: 0.214
  12. Lana SE, Jackson TL, Burnett RC, Morley PS, Avery AC. Utility of polymerase chain reaction for analysis of antigen receptor rearrangement in staging and predicting prognosis in dogs with lymphoma. J Vet Intern Med. 2006 Mar-Apr; 20(2):329-34.
    View in: PubMed
    Score: 0.206
  13. Mullins MN, Dernell WS, Withrow SJ, Ehrhart EJ, Thamm DH, Lana SE. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004). J Am Vet Med Assoc. 2006 Jan 01; 228(1):91-5.
    View in: PubMed
    Score: 0.204
  14. Das S, Schlemmer SN, Idate R, Lana SE, Regan DP, Thamm DH, Duval DL. Comparative genomic and clinicopathological analysis uncovers contrasting molecular profiles of canine and human thyroid carcinomas. Commun Biol. 2025 Dec 06; 9(1):4.
    View in: PubMed
    Score: 0.203
  15. Hillers KR, Dernell WS, Lafferty MH, Withrow SJ, Lana SE. Incidence and prognostic importance of lymph node metastases in dogs with appendicular osteosarcoma: 228 cases (1986-2003). J Am Vet Med Assoc. 2005 Apr 15; 226(8):1364-7.
    View in: PubMed
    Score: 0.194
  16. Lana SE, Dernell WS, Lafferty MH, Withrow SJ, LaRue SM. Use of radiation and a slow-release cisplatin formulation for treatment of canine nasal tumors. Vet Radiol Ultrasound. 2004 Nov-Dec; 45(6):577-81.
    View in: PubMed
    Score: 0.188
  17. Slinkard PT, Lana SE, Frank CB, Griffin LR. Multi-modality imaging and therapeutics used in a case of canine spinal nephroblastoma. Can Vet J. 2022 08; 63(8):811-818.
    View in: PubMed
    Score: 0.161
  18. Nolan MW, Uzan OC, Green NA, Lana SE, Lascelles BDX. Intensity of perioperative analgesia but not pre-treatment pain is predictive of survival in dogs undergoing amputation plus chemotherapy for extremity osteosarcoma. Vet Comp Oncol. 2022 Sep; 20(3):568-576.
    View in: PubMed
    Score: 0.157
  19. Frankhouse KA, Rout ED, Hughes KL, Labadie JD, Yoshimoto JA, Lana SE, Avery PR, Avery AC. An aggressive CD4- CD8- T-cell neoplasm in young English bulldogs. Vet Comp Oncol. 2022 Jun; 20(2):416-426.
    View in: PubMed
    Score: 0.154
  20. Das S, Idate R, Regan DP, Fowles JS, Lana SE, Thamm DH, Gustafson DL, Duval DL. Immune pathways and TP53 missense mutations are associated with longer survival in canine osteosarcoma. Commun Biol. 2021 10 11; 4(1):1178.
    View in: PubMed
    Score: 0.152
  21. Cronise KE, Das S, Hernandez BG, Regan DP, Dailey DD, McGeachan RI, Lana SE, Page RL, Gustafson DL, Duval DL. Characterizing the molecular and immune landscape of canine bladder cancer. Vet Comp Oncol. 2022 Mar; 20(1):69-81.
    View in: PubMed
    Score: 0.148
  22. LeBlanc AK, Mazcko CN, Cherukuri A, Berger EP, Kisseberth WC, Brown ME, Lana SE, Weishaar K, Flesner BK, Bryan JN, Vail DM, Burton JH, Willcox JL, Mutsaers AJ, Woods JP, Northrup NC, Saba C, Curran KM, Leeper H, Wilson-Robles H, Wustefeld-Janssens BG, Lindley S, Smith AN, Dervisis N, Klahn S, Higginbotham ML, Wouda RM, Krick E, Mahoney JA, London CA, Barber LG, Balkman CE, McCleary-Wheeler AL, Suter SE, Martin O, Borgatti A, Burgess K, Childress MO, Fidel JL, Allstadt SD, Gustafson DL, Selmic LE, Khanna C, Fan TM. Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs. Clin Cancer Res. 2021 06 01; 27(11):3005-3016.
    View in: PubMed
    Score: 0.146
  23. Lana SE, Ogilvie GK, Hansen RA, Powers BE, Dernell WS, Withrow SJ. Identification of matrix metalloproteinases in canine neoplastic tissue. Am J Vet Res. 2000 Feb; 61(2):111-4.
    View in: PubMed
    Score: 0.135
  24. Lana SE, Dernell WS, LaRue SM, Lafferty MJ, Douple EB, Brekke JH, Withrow SJ. Slow release cisplatin combined with radiation for the treatment of canine nasal tumors. Vet Radiol Ultrasound. 1997 Nov-Dec; 38(6):474-8.
    View in: PubMed
    Score: 0.116
  25. Curran KM, Schaffer PA, Frank CB, Lana SE, Hamil LE, Burton JH, Labadie J, Ehrhart EJ, Avery PR. BCL2 and MYC are expressed at high levels in canine diffuse large B-cell lymphoma but are not predictive for outcome in dogs treated with CHOP chemotherapy. Vet Comp Oncol. 2017 Dec; 15(4):1269-1279.
    View in: PubMed
    Score: 0.106
  26. Rodrigues LC, Holmes KE, Thompson V, Piskun CM, Lana SE, Newton MA, Stein TJ. Osteosarcoma tissues and cell lines from patients with differing serum alkaline phosphatase concentrations display minimal differences in gene expression patterns. Vet Comp Oncol. 2016 Jun; 14(2):e58-69.
    View in: PubMed
    Score: 0.096
  27. Rao S, Lana S, Eickhoff J, Marcus E, Avery PR, Morley PS, Avery AC. Class II major histocompatibility complex expression and cell size independently predict survival in canine B-cell lymphoma. J Vet Intern Med. 2011 Sep-Oct; 25(5):1097-105.
    View in: PubMed
    Score: 0.075
  28. Devitt JJ, Maranon DG, Ehrhart EJ, Bachand AM, Lana SE, LaRue SM. Correlations between numerical chromosomal aberrations in the tumor and peripheral blood in canine lymphoma. Cytogenet Genome Res. 2009; 124(1):12-8.
    View in: PubMed
    Score: 0.064
  29. Miller AG, Morley PS, Rao S, Avery AC, Lana SE, Olver CS. Anemia is associated with decreased survival time in dogs with lymphoma. J Vet Intern Med. 2009 Jan-Feb; 23(1):116-22.
    View in: PubMed
    Score: 0.063
  30. Rebhun RB, Lana SE, Ehrhart EJ, Charles JB, Thamm DH. Comparative analysis of survivin expression in untreated and relapsed canine lymphoma. J Vet Intern Med. 2008 Jul-Aug; 22(4):989-95.
    View in: PubMed
    Score: 0.061
  31. Petty JC, Lana SE, Thamm DH, Charles JB, Bachand AM, Bush JM, Ehrhart EJ. Glucose transporter 1 expression in canine osteosarcoma. Vet Comp Oncol. 2008 Jun; 6(2):133-40.
    View in: PubMed
    Score: 0.060
  32. Williams MJ, Avery AC, Lana SE, Hillers KR, Bachand AM, Avery PR. Canine lymphoproliferative disease characterized by lymphocytosis: immunophenotypic markers of prognosis. J Vet Intern Med. 2008 May-Jun; 22(3):596-601.
    View in: PubMed
    Score: 0.059
  33. Fosmire SP, Thomas R, Jubala CM, Wojcieszyn JW, Valli VE, Getzy DM, Smith TL, Gardner LA, Ritt MG, Bell JS, Freeman KP, Greenfield BE, Lana SE, Kisseberth WC, Helfand SC, Cutter GR, Breen M, Modiano JF. Inactivation of the p16 cyclin-dependent kinase inhibitor in high-grade canine non-Hodgkin's T-cell lymphoma. Vet Pathol. 2007 Jul; 44(4):467-78.
    View in: PubMed
    Score: 0.057
  34. Hillers KR, Lana SE, Fuller CR, LaRue SM. Effects of palliative radiation therapy on nonsplenic hemangiosarcoma in dogs. J Am Anim Hosp Assoc. 2007 Jul-Aug; 43(4):187-92.
    View in: PubMed
    Score: 0.057
  35. Walter CU, Biller BJ, Lana SE, Bachand AM, Dow SW. Effects of chemotherapy on immune responses in dogs with cancer. J Vet Intern Med. 2006 Mar-Apr; 20(2):342-7.
    View in: PubMed
    Score: 0.052
  36. Selting KA, Ogilvie GK, Gustafson DL, Long ME, Lana SE, Walton JA, Hansen RA, Turner AS, Laible I, Fettman MJ. Evaluation of the effects of dietary n-3 fatty acid supplementation on the pharmacokinetics of doxorubicin in dogs with lymphoma. Am J Vet Res. 2006 Jan; 67(1):145-51.
    View in: PubMed
    Score: 0.051
  37. Williams LE, Rassnick KM, Power HT, Lana SE, Morrison-Collister KE, Hansen K, Johnson JL. CCNU in the treatment of canine epitheliotropic lymphoma. J Vet Intern Med. 2006 Jan-Feb; 20(1):136-43.
    View in: PubMed
    Score: 0.051
  38. Mullins MN, Lana SE, Dernell WS, Ogilvie GK, Withrow SJ, Ehrhart EJ. Cyclooxygenase-2 expression in canine appendicular osteosarcomas. J Vet Intern Med. 2004 Nov-Dec; 18(6):859-65.
    View in: PubMed
    Score: 0.047
  39. Williams LE, Gliatto JM, Dodge RK, Johnson JL, Gamblin RM, Thamm DH, Lana SE, Szymkowski M, Moore AS. Carcinoma of the apocrine glands of the anal sac in dogs: 113 cases (1985-1995). J Am Vet Med Assoc. 2003 Sep 15; 223(6):825-31.
    View in: PubMed
    Score: 0.043
  40. Kazmierski KJ, Ogilvie GK, Fettman MJ, Lana SE, Walton JA, Hansen RA, Richardson KL, Hamar DW, Bedwell CL, Andrews G, Chavey S. Serum zinc, chromium, and iron concentrations in dogs with lymphoma and osteosarcoma. J Vet Intern Med. 2001 Nov-Dec; 15(6):585-8.
    View in: PubMed
    Score: 0.038
  41. Leibman NF, Lana SE, Hansen RA, Powers BE, Fettman MJ, Withrow SJ, Ogilvie GK. Identification of matrix metalloproteinases in canine cutaneous mast cell tumors. J Vet Intern Med. 2000 Nov-Dec; 14(6):583-6.
    View in: PubMed
    Score: 0.036
  42. Hahn KA, Legendre AM, Shaw NG, Phillips B, Ogilvie GK, Prescott DM, Atwater SW, Carreras JK, Lana SE, Ladue T, Rusk A, Kinet JP, Dubreuil P, Moussy A, Hermine O. Evaluation of 12- and 24-month survival rates after treatment with masitinib in dogs with nonresectable mast cell tumors. Am J Vet Res. 2010 Nov; 71(11):1354-61.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)